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OBJECTIVE: To characterize at risk patients for early (defined as the period of 90 days post-discharge) readmission due to heart failure and
overall death.
BACKGROUND: Albeit we have assisted to a consistent decline in the rate of heart failure hospitalizations, surprisingly, short-term readmission
and mortality persist high, irrespective of clinical innovations and guideline directed management, representing a tremendous health care
burden.
PARTNERSHIPS 
 
 
 
 
 
 
 
 
 
 
 
N=65 HF patients
Mean age: 79.2 (SD 10.8)
Median follow-up : 13.7 months
[Q1: 6.7 to Q3: 18.9]
RESULTS
Characteristics Patients (n=65)
Age, mean (SD) 79.2 ± 10.8
Female Gender, n (%) 37 (56.9)
Hypertension, n (%) 58 (89.2)
Type 2 Diabetes, n (%) 25 (38.5)
Dyslipidemia, n (%) 41 (63.1)
Obesity, n (%) 17 (26.2)
Atrial Fibrillation, n (%) 28 (43.1)
Family History of CVD, n (%) 31 (47.7)
Tabagism, n (%) 21 (32.3)
Chronic Kidney Disease, n (%) 34 (52.3)
GFR (Baseline), median 57.8 (43.8 - 82.2)
GFR (Admission), median 47.9 (33.2 - 68.1)
Previous Acute Myocardial Infarction, n (%) 27 (41.5)
Hypertensive Cardiomyopathy, n (%) 44 (67.7)
Ischemic Cardiomyopathy, n (%) 22 (33.8)
Valvular Cardiomyopathy, n (%) 56 (86.2)
LVEF, mean (SD) 50.38 ± 19.07
NYHA class III, n (%) 43 (66.2)
ACE Inhibitor, n (%) 43 (66.2)
Beta Blocker, n (%) 38 (58.5)
Mineralocorticoid Receptor Antagonists, n (%) 19 (29.2)
Angiotensin II Receptor Blocker, n (%) 11 (16.9)
Loop Diuretic, n (%) 54 (83.1)
Digoxin, n (%) 8 (12.3)
Values are median (IQR), n (%), or mean±SD.
IQR: interquartile range and minimum/maximum, SD: standard deviation, CVD:
cardiovascular disease, GFR: glomerular filtration rate, ACE: Angiotensin-
Converting-Enzyme.
METHODS: Adult patients admitted, to an Internal Medicine ward, with acute decompensated heart failure in class III or IV of New York Heart
Association (NYHA) were assessed. Subgroup analysis was performed according to the left ventricular ejection fraction (LVEF) in light of the
current European Society of Cardiology guidelines. Comparison between patients with and without each of the events was performed for all
variables using t test or Wilcoxon Rank test as applicable. Categorical variables were summarized by relative and absolute frequencies, and
compared using chi-squared test or Fisher’s Exact test as applicable. Univariate Cox proportional hazard model was used to evaluate the
relationship between variables and outcomes.
CONCLUSION:
- The high short-term readmission and mortality rates acknowledged are consentaneous with other studies.
- The LOS and the number of hospitalizations were associated with worse short-term outcome.
- Based on these findings, one can assume that the requirement for hospitalization is a relevant predictor of poor outcome as it reflects more
severe disease, and that patients hospitalized longer or repeatedly face a worse outcome.
- We believe that these results corroborate the assumption that HF has a tremendous social and economic impact.
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Table 1 – General baseline characteristics
Readmission rate 
33.8%
90-DAY POST-DISCHARGE 
13.8%
30-DAY POST-DISCHARGE YEAR 
61.5%
10.8% Mortality18.5% Mortality 36.9% Mortality
The length of stay (LOS) represented a risk factor for short-term 
readmission 
Characteristic
LOS (general population)
LOS (HFrEF) 
Number Hospitalizations (g. population)
Number Hospitalizations (HFmrEF)
LOS/Short-term mortality
HR 95% CI P value
1.022 1.009-1.036 <0.001
1.029 1.008-1.036 0.006
1.543 1.224-1.945 <0.001
2.814 1.075-7.365 0.035
1.016 0.999-1.032 0.062
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Forest Plot of Hazard Ratios by Patient Subgroups
LOS, length of stay; HR, Hazard ratio.; HFrEF, Heart Failure with Reduced Ejection Fraction; HFmrEF, 
Mid-Range Ejection Fraction 
Short-term readmission
The year mortality was 36.9% and 40% of the patients had deceased 
at the end of the follow-up
5 6 7 8
Mortality rate 
